molecular.jpg
Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update
March 29, 2024 08:21 ET | Molecular Templates, Inc.
AUSTIN, Texas, March 29, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and...
BurgerFiAnthonys.png
BurgerFi to Report Fourth Quarter and Fiscal Year 2023 Financial Results on April 1, 2024
March 29, 2024 08:00 ET | BurgerFi International
FORT LAUDERDALE, Fla., March 29, 2024 (GLOBE NEWSWIRE) -- BurgerFi International, Inc. (NASDAQ: BFI, BFIIW) (“BurgerFi”), owner of one of the nation’s leading fast-casual “better burger” dining...
Gentex-black.jpg
Gentex Schedules First Quarter 2024 Earnings Release Date and Conference Call
March 29, 2024 08:00 ET | Gentex Corporation
Gentex schedules Q1 2024 earnings release and conference call for April 26.
KALA BIO logo.jpg
KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
March 29, 2024 08:00 ET | KALA BIO, Inc.
-- Advancing ongoing Phase 2b CHASE trial of KPI-012 for PCED; topline data targeted by year-end 2024 ---- Exploring opportunities to expand KPI-012 into additional corneal indications ---- Cash...
galectin.jpg
Galectin Therapeutics Reports 2023 Financial Results and Provides Business Update
March 29, 2024 08:00 ET | Galectin Therapeutics Inc.
NORCROSS, Ga., March 29, 2024 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results...
SAB_Logo.png
SAB Biotherapeutics Reports Full Year 2023 Operating and Financial Results
March 29, 2024 07:15 ET | SAB Biotherapeutics, Inc.
Sioux Falls, SD , March 29, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics Reports Full Year 2023 Operating and Financial Results March 29, 2024 SAB-142 Phase 1 trial on track for data release...
VSAC Logo.png
Vision Sensing Acquisition Corp. Announces Intention to Extend Period to Consummate Initial Business Combination to May 3, 2024
March 29, 2024 06:45 ET | Vision Sensing Acquisition Corp.
Vision Sensing Acquisition Corp. Announces Intention to Extend Period to Consummate Initial Business Combination to May 3, 2024
Logo.png
Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023
March 29, 2024 06:15 ET | Guardion Health Sciences, Inc.
Viactiv® Product Line Generated Net Revenues of Approximately $11.9 Million for the Year Ended December 31, 2023, an Increase of Approximately 12% as Compared to the Year Ended December 31, 2022 ...
Adlai Nortye logo.png
Adlai Nortye Announces Appointment of Dr. Archie Tse as the Head of Research & Development
March 29, 2024 06:00 ET | Adlai Nortye Ltd.
SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, March 29, 2024 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or “Adlai Nortye”), a clinical-stage...
Bilibili Inc. Announces Completion of the Repurchase Right Offer for 1.375% Convertible Senior Notes due 2026
March 29, 2024 05:00 ET | Bilibili Inc.
SHANGHAI, China, March 29, 2024 (GLOBE NEWSWIRE) -- Bilibili Inc. (“Bilibili” or the “Company”) (NASDAQ: BILI and HKEX: 9626), an iconic brand and a leading video community for young generations in...